Candel Therapeutics, Inc.: director Papa Joseph C received 1,325 shares

What happened

• Papa Joseph C, a director of Candel Therapeutics, Inc., received an award of 1,325 shares at $8.68 per share on Sep 30, 2026, for a total reported value of $11,496 (derivative acquisition).
• The filing reports the award was granted in lieu of cash compensation and the underlying award quantity was fully vested at grant.

Key details

• Transaction date and price: Sep 30, 2026 — award of 1,325 shares at $8.68 per share.
• Total value reported: $11,496.
• Shares owned after the transaction: not reported in this Form 4.
• Footnote: the award was granted in lieu of normal quarterly cash payments; the underlying award quantity was fully vested at time of grant (Footnote F1).
• Filing date: Oct 2, 2026; no late-filing indicator shown in the Form 4.

Why it may matter

• This was an award/grant (derivative acquisition) issued in lieu of cash compensation; it was not a market purchase or sale.
• This filing does not show why the insider traded or why the company acted.